1. seed
  2. The Buzz: Flawed Funding for Cancer Research?

The Buzz: Flawed Funding for Cancer Research?

By ejohnson on June 30, 2009.
i-21a2d5cb57dca06b7eeef18595b34964-ProstateCancerResearch.jpg

In a recent New York Times article, Grant System Leads Cancer Researchers to Play It Safe, the National Cancer Institute and parent institution NIH were taken to task for their biased funding of low-risk studies, which lead to what the article claims are few breakthroughs in effective treatment. The article critiques the funding of research that produces only "incremental progress," or that focuses on prevention through diet and health. But, as ScienceBlogger Orac points out, it fails to provide evidence that granting funds to riskier projects--with the potential for higher impact--would in fact be an improvement. And Mike the Mad Biologist offers an alternative solution to the funding fix: increased funding of large-scale, rather than long-shot, research.

Tags
medicine

More like this

Are we playing it too safe in cancer research?
A couple of weeks ago, NEWSWEEK science columnist Sharon Begley wrote an article entitled From Bench To Bedside: Academia slows the search for cures. It was a rather poorly argued bit of polemic, backed up only with anecdotes that came across as sour grapes by scientists whose grant proposals the…
The Culture of Caution at NIH and Academia's Role
Yesterday's article by Gina Kolata about cancer research mistakes a symptom--caution due to a perceived lack of funding--for the disease, which is the symbiosis between academia and the NIH. Don't get me wrong, a lot of research should involve academics. But the priorities of NIH have become…
Singles, Grand Slams, and Losing the War on Cancer
The recent issues of Newsweek and TIME both carried sobering articles about the state of cancer research. Newsweekâs Sharon Begley reports that cancer is on track to claim 565,650 lives in the U.S. this year, and that number isnât a whole lot better than it was in 1971, when President Nixon signed…
Academia: Slowing down the search for cures? Other voices
On Friday, I expressed my irritation at the misunderstanding of science by NEWSWEEK's science columnist Sharon Begley, in which she opines that it is those nasty basic scientists who insist on learning new science and new physiological mechanisms of disease that are devaluing translational and…